Boothbay Fund Management LLC Sells 133,415 Shares of Establishment Labs Holdings Inc. $ESTA

Boothbay Fund Management LLC lessened its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 30.8% during the fourth quarter, Holdings Channel.com reports. The fund owned 299,291 shares of the company’s stock after selling 133,415 shares during the period. Establishment Labs accounts for 0.3% of Boothbay Fund Management LLC’s holdings, making the stock its 13th largest holding. Boothbay Fund Management LLC’s holdings in Establishment Labs were worth $21,812,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Nantahala Capital Management LLC lifted its position in shares of Establishment Labs by 11.1% in the 3rd quarter. Nantahala Capital Management LLC now owns 1,973,492 shares of the company’s stock worth $80,893,000 after purchasing an additional 197,962 shares during the period. Bamco Inc. NY lifted its position in shares of Establishment Labs by 30.2% in the 3rd quarter. Bamco Inc. NY now owns 1,181,824 shares of the company’s stock worth $48,443,000 after purchasing an additional 274,287 shares during the period. Tyro Capital Management LLC lifted its position in shares of Establishment Labs by 1.0% in the 3rd quarter. Tyro Capital Management LLC now owns 1,077,456 shares of the company’s stock worth $44,165,000 after purchasing an additional 10,735 shares during the period. William Blair Investment Management LLC lifted its position in shares of Establishment Labs by 17.6% in the 3rd quarter. William Blair Investment Management LLC now owns 1,017,543 shares of the company’s stock worth $41,709,000 after purchasing an additional 152,299 shares during the period. Finally, Goldman Sachs Group Inc. lifted its position in shares of Establishment Labs by 117.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 811,536 shares of the company’s stock worth $59,145,000 after purchasing an additional 438,206 shares during the period. 72.91% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Establishment Labs

In related news, Director Quiros Juan Jose Chacon sold 105,000 shares of Establishment Labs stock in a transaction dated Wednesday, May 6th. The shares were sold at an average price of $75.42, for a total transaction of $7,919,100.00. Following the completion of the transaction, the director directly owned 927,504 shares of the company’s stock, valued at $69,952,351.68. This trade represents a 10.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Over the last three months, insiders have sold 330,000 shares of company stock worth $22,854,538. Company insiders own 9.99% of the company’s stock.

Wall Street Analysts Forecast Growth

ESTA has been the subject of several research analyst reports. Stephens raised their target price on shares of Establishment Labs from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 25th. Needham & Company LLC raised their target price on shares of Establishment Labs from $84.00 to $86.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Mizuho raised their target price on shares of Establishment Labs from $90.00 to $100.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Wall Street Zen cut shares of Establishment Labs from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. Finally, BTIG Research raised their target price on shares of Establishment Labs from $88.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Seven equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Establishment Labs presently has an average rating of “Moderate Buy” and a consensus target price of $87.14.

Establishment Labs Trading Down 0.2%

Shares of NASDAQ ESTA opened at $82.39 on Thursday. Establishment Labs Holdings Inc. has a 1 year low of $33.35 and a 1 year high of $86.00. The stock has a market cap of $2.42 billion, a P/E ratio of -55.29 and a beta of 1.11. The firm has a 50-day moving average of $70.25 and a 200 day moving average of $69.48. The company has a debt-to-equity ratio of 16.82, a current ratio of 2.96 and a quick ratio of 1.91.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings results on Thursday, May 7th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.10). Establishment Labs had a negative net margin of 19.05% and a negative return on equity of 218.77%. The business had revenue of $59.88 million for the quarter, compared to analysts’ expectations of $57.40 million. During the same period last year, the business earned ($0.70) earnings per share. The company’s revenue was up 44.7% on a year-over-year basis. As a group, sell-side analysts expect that Establishment Labs Holdings Inc. will post -1.07 EPS for the current fiscal year.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.